Previous studies of patients with myotonic dystrophy have demonstrated hyperinsulinism after glucose loading. This hyperinsulinism has been attributed by some investigators to tissue insulin resistance. We have directly studied insulin sensitivity of forearm muscle in patients having such hyperinsulinism. The effect of an intrabrachial arterial insulin infusion (100 mu U/kg per min) on glucose uptake was determined in six cases of myotonic dystrophy, six normal subjects, and in seven disease control subjects with myotonia or wasting from other disorders. There was no significant difference in insulin tolerance comparing myotonic dystrophy patients to the normal and disease control groups. Glucose tolerance and basal insulin levels were normal in the myotonic dystrophy patients, but hyperinsulinism occurred after glucose ingestion. After 25 min of intra-arterial insulin, the mean peak muscle glucose uptake in myotonic dystrophy was 2.54 +/- 0.54 mu mol/min per 100 ml forearm compared to 5.24 +/- 0.86 mu mol/min per 100 ml for disease controls (P is less than 0.05). Myotonic dystrophy patients showed a peak glucose uptake increment of only 2.6 +/- 0.2-fold over basal contrasted with the disease control value of 6.5 +/- 1.0-fold (P is less than 0.02) and the normal control value of 8.8 +/- 1.1-fold (P is less than 0.01). Thus, there was an absolute as well as a relative decrease in muscle insulin sensitivity in myotonic dystrophy patients compared to both control groups. The peak increments in arterio-superficial venous glucose concentration differences after insulin infusion were not significantly different comparing myotonic dystrophy and control groups. These data suggest that in myotonic dystrophy, there is insulin insensitivity of skeletal muscle.
R T Moxley III, R C Griggs, D Goldblatt, V VanGelder, B E Herr, R Thiel
Title and authors | Publication | Year |
---|---|---|
Skeletal muscle disorders as risk factors for type 2 diabetes
Tammineni ER, Manno C, Oza G, Figueroa L |
Molecular and cellular endocrinology | 2025 |
Use of HSALR female mice as a model for the study of myotonic dystrophy type I
Carrascosa-Sàez M, Colom-Rodrigo A, González-Martínez I, Pérez-Gómez R, García-Rey A, Piqueras-Losilla D, Ballestar A, Llamusí B, Cerro-Herreros E, Artero R |
Lab Animal | 2025 |
David Goldblatt (1930-2007).
Triarhou LC |
Journal of neurology | 2024 |
Investigation of Glucose Metabolism by Continuous Glucose Monitoring and Validation of Dipeptidyl Peptidase 4 Inhibitor Use in Patients with Myotonic Dystrophy Type 1.
Takada H, Matsumura T, Shimamura H, Matsui M, Kon S, Fukumoto A, Kubota T, Yoshida K, Iwahashi H, Takahashi MP |
Journal of clinical medicine | 2024 |
Brain Pathogenesis and Potential Therapeutic Strategies in Myotonic Dystrophy Type 1
J Liu, ZN Guo, XL Yan, Y Yang, S Huang |
Frontiers in aging neuroscience | 2021 |
Endocrine Dysfunction in Patients With Myotonic Dystrophy
SJ Winters |
The Journal of clinical endocrinology and metabolism | 2021 |
Cellular Mechanics and Biophysics: Structure and Function of Basic Cellular Components Regulating Cell Mechanics
CT Mierke |
2020 | |
Insulin Signaling as a Key Moderator in Myotonic Dystrophy Type 1
S Nieuwenhuis, K Okkersen, J Widomska, P Blom, , B van Engelen, JC Glennon |
Frontiers in neurology | 2019 |
Diversification of the muscle proteome through alternative splicing
K Nakka, C Ghigna, D Gabellini, FJ Dilworth |
Skeletal Muscle | 2018 |
Receptor and post-receptor abnormalities contribute to insulin resistance in myotonic dystrophy type 1 and type 2 skeletal muscle
LV Renna, F Bosè, S Iachettini, B Fossati, L Saraceno, V Milani, R Colombo, G Meola, R Cardani, V Mouly |
PloS one | 2017 |
Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics: DM1 disease mechanisms and therapeutics
A Chau, A Kalsotra |
Developmental Dynamics | 2015 |
Surgical treatment of obesity in DM1 – a case report and a review of the literature
K Håkansson, S Kostic, C Lindberg |
Neuromuscular Disorders | 2015 |
Myotonic Dystrophy
CA Thornton |
Neurologic Clinics | 2014 |
Muscleblind-like 1 activates insulin receptor exon 11 inclusion by enhancing U2AF65 binding and splicing of the upstream intron
GV Echeverria, TA Cooper |
Nucleic Acids Research | 2013 |
RNA-binding proteins in microsatellite expansion disorders: Mediators of RNA toxicity
GV Echeverria, TA Cooper |
Brain Research | 2012 |
Handbook of Clinical Neurology
T Ashizawa, PS Sarkar |
Muscular Dystrophies | 2011 |
The differences of sarcopenia-related phenotypes: effects of gender and population
K Zhong, S Lei, F Yang, X Chen, L Tan, X Zhu, Q Tian, H Deng |
European Review of Aging and Physical Activity | 2011 |
Differential Muscle Gene Expression as a Function of Disease Progression in Goto-Kakizaki Diabetic Rats
J Nie, B Xue, S Sukumaran, WJ Jusko, DC Dubois, RR Almon |
Molecular and Cellular Endocrinology | 2011 |
Adipose Tissue Deficiency and Chronic Inflammation in Diabetic Goto-Kakizaki Rats
B Xue, S Sukumaran, J Nie, WJ Jusko, DC DuBois, RR Almon, J Vina |
PloS one | 2011 |
CUGBP1 overexpression in mouse skeletal muscle reproduces features of myotonic dystrophy type 1
AJ Ward, M Rimer, JM Killian, JJ Dowling, TA Cooper |
Human Molecular Genetics | 2010 |
Dramatic Improvement of Blood Glucose Control after Pioglitazone Treatment in Poorly Controlled Over-weight Diabetic Patients with Myotonic Dystrophy
H ABE, T MITA, K KUDO, T FUNAYAMA, M TOKORO, H KAGA, F IKEDA, A KANAZAWA, T HIROSE, R KAWAMORI, H WADA |
Endocrine Journal | 2009 |
Frequency and predictors of nonalcoholic fatty liver disease in myotonic dystrophy
K Shieh, JM Gilchrist, K Promrat |
Muscle & Nerve | 2009 |
A cross-sectional study for glucose intolerance of myotonic dystrophy
T Matsumura, H Iwahashi, T Funahashi, MP Takahashi, T Saito, K Yasui, T Saito, A Iyama, K Toyooka, H Fujimura, S Shinno |
Journal of the Neurological Sciences | 2009 |
High-fat diet induced adiposity and insulin resistance in mice lacking the myotonic dystrophy protein kinase
E Llagostera, MC Carmona, M Vicente, RM Escorihuela, P Kaliman |
FEBS Letters | 2009 |
Trinucleotide Repeat Disorders
HT Orr, HY Zoghbi |
Annual Review of Neuroscience | 2007 |
Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action
E Llagostera, D Catalucci, L Marti, M Liesa, M Camps, TP Ciaraldi, R Kondo, S Reddy, WH Dillmann, M Palacin, A Zorzano, P Ruiz-Lozano, R Gomis, P Kaliman |
PloS one | 2007 |
Role of Myotonic Dystrophy Protein Kinase (DMPK) in Glucose Homeostasis and Muscle Insulin Action
E Llagostera, D Catalucci, L Marti, M Liesa, M Camps, TP Ciaraldi, R Kondo, S Reddy, WH Dillmann, M Palacin, A Zorzano, P Ruiz-Lozano, R Gomis, P Kaliman, B McCabe |
PloS one | 2007 |
RNA-mediated neuromuscular disorders
LP Ranum, TA Cooper |
Annual Review of Neuroscience | 2006 |
RNA-dominant diseases
RJ Osborne, CA Thornton |
Human Molecular Genetics | 2006 |
Insulin Receptor Splicing Alteration in Myotonic Dystrophy Type 2
RS Savkur, AV Philips, TA Cooper, JC Dalton, ML Moseley, LP Ranum, JW Day |
The American Journal of Human Genetics | 2004 |
Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy
RS Savkur, AV Philips, TA Cooper |
Nature Genetics | 2001 |
Myotonic Dystrophy
G Tiscornia, MS Mahadevan |
Molecular Cell | 2000 |
Leptin after IGF-I generation test in a patient with hypopituitarism and myotonic dystrophy disease
J M Gómez, J A Martínez-Matos |
Pituitary | 2000 |
Insulin-Like Growth Factor I Circumvents Defective Insulin Action in Human Myotonic Dystrophy Skeletal Muscle Cells1
D Furling, A Marette, J Puymirat |
Endocrinology | 1999 |
Impaired cerebral glucose metabolism in myotonic dystrophy: a triplet-size dependent phenomenon
D Annane, M Fiorelli, B Mazoyer, S Pappata, B Eymard, H Radvanyi, C Junien, M Fardeau, P Merlet, P Gajdos, A Syrota, Y Sansom, D Duboc |
Neuromuscular Disorders | 1998 |
Study on growth hormone and insulin secretion in myotonic dystrophy
JM Sez, JM Real, MF Castaer, MA Moreno, JA Matos, JS Ramn |
The Clinical Investigator | 1994 |
Forearm 3-methylhistidine efflux in myotonic dystrophy
Z Rifai, WJ Kingston, B McCraith, RT Moxley |
Annals of Neurology | 1993 |
Diacylglycerol/protein kinase C signalling: a mechanism for insulin resistance?
E Shmueli, KG Alberti, CO Record |
Journal of Internal Medicine | 1993 |
Glucose intolerance in first-degree relatives of patients with Friedreich's ataxia is associated with insulin resistance: Evidence for a closely linked inherited trait
IG Fantus, N Janjua, H Senni, E Andermann |
Metabolism | 1991 |
Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy
AJ Krentz, AC Williams, M Nattrass |
Metabolism | 1991 |
Mechanism of muscle wasting in myotonic dystrophy
RC Griggs, R Jozefowicz, W Kingston, KS Nair, BE Herr, D Halliday |
Annals of Neurology | 1990 |
Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy
AJ Krentz, NH Coles, AC Williams, M Nattrass |
Metabolism | 1990 |
Enhancement of insulin action after oral glucose ingestion
WJ Kingston, JN Livingston, RT 3rd |
Journal of Clinical Investigation | 1986 |
Effect of testosterone on muscle protein synthesis in myotonic dystrophy
RC Griggs, D Halliday, W Kingston, RT Moxley |
Annals of Neurology | 1986 |
Glucose intolerance in Friedreich's Ataxia: Association with insulin resistance and decreased insulin binding
RJ Khan, E Andermann, IG Fantus |
Metabolism | 1986 |
Abnormal insulin homeostasis in myotonic dystrophy
G Karpati |
Trends in Neurosciences | 1985 |
In vivo estimation of muscle protein synthesis in myotonic dystrophy
D Halliday, GC Ford, RH Edwards, MJ Rennie, RC Griggs |
Annals of Neurology | 1985 |
Whole body insulin resistance in myotonic dystrophy
RT Moxley, AJ Corbett, KL Minaker, JW Rowe |
Annals of Neurology | 1984 |
An insulin receptor defect in murine muscular dystrophy
WW Hofmann |
Muscle & Nerve | 1984 |
Muscle wasting in muscular dystrophy: Decreased protein synthesis or increased degradation?
RC Griggs, MJ Reinnie |
Annals of Neurology | 1983 |
Taurine and hyperexcitable human muscle: Effects of taurine on potassium-induced hyperexcitability of dystrophic myotonic and normal muscles
L Durelli, R Mutani, F Fassio, A Satta, E Bartoli |
Annals of Neurology | 1982 |
Insulin receptors in myotonic dystrophy: A study with mononuclear leucocytes and erythrocytes
P Fratino, G Bellomo, R Bellazzi, PL Nicotera, G Sandrini, G Nappi |
The Italian Journal of Neurological Sciences | 1982 |
Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy
RT 3rd, JN Livingston, DH Lockwood, RC Griggs, RL Hill |
Proceedings of the National Academy of Sciences | 1981 |
Mechanisms of insulin resistance in man
RA Rizza, LJ Mandarino, JE Gerich |
The American Journal of Medicine | 1981 |
Familial Insulin Resistance with Acanthosis Nigricans, Acral Hypertrophy, and Muscle Cramps
JS Flier, JB Young, L Landsberg |
New England Journal of Medicine | 1980 |
Protein synthesis and degradation in skeletal muscle of normal and dystrophic hamsters
JB Li |
American journal of physiology. Endocrinology and metabolism | 1980 |
Metabolic implications of distal atrophy
RT Moxley, RC Griggs, WR Markesbery, V Vangelder |
Journal of the Neurological Sciences | 1978 |